Innovative and committed to patients worldwide.
CSL Behring is a global biotechnology leader driven by its promise to save lives. At our manufacturing site in Bern, Switzerland, we develop and manufacture life-saving therapies for people living with serious and rare diseases around the world.
We are currently looking for a Senior Scientist Digital Quality Control (100%) – (m/f/d) to join our Global Quality Control organization.
In this role, you will play a key part in driving the digital transformation of our QC laboratories by implementing and continuously improving our global Laboratory Execution System (LES). Working closely with QC laboratories, Global Engineering and IT across multiple manufacturing sites, you will help shape the future of digital laboratory operations and contribute to the standardization of Quality Control processes worldwide.
As part of our Global Digital QC team, you will primarily support the QC laboratories in Bern while collaborating closely with colleagues across Australia, Germany, Switzerland and the United States.
This international role offers the opportunity to develop deep expertise in one of CSL Behring's key digital laboratory platforms and actively shape the future of Quality Control digitalization across our manufacturing network.
You will work at the intersection of laboratory science, digital technology and global Quality Control, helping translate analytical laboratory processes into standardized and reliable digital workflows while contributing to the continued evolution of our global QC capabilities.
Interested in this opportunity? We look forward to receiving your application. Please submit your CV, employment references and degree certificates together as one file.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
